九州通医药集团简介PPT中英文版（2018年年报数据+一季报）

PPT 内容
PPT 图集

1. 做中国医药健康产业最佳服务商To be the best service provider in China’s pharmaceutical and health industry 股票代码：600998 The code of Stock+医药分销 Distribution医药工业 Manufacture医药零售 Retail医药电商 E-commerce2020/11/271
2. 西药分销 Western drug distribution医药通九州健康送万家中药分销 TCM distribution器械分销 Medical device distribution消费品分销 FMCG distribution中国最大民营医药商业企业 THE LARGEST PRIVATE PHARMACEUTICAL DISTRIBUTION ENTERPRISE IN CHINA2020/11/272
3. 业务概要及经营情况经营模式及核心优势Business model and core strengths公司基本情况介绍Company overview未来发展与经营规划Future business development and planningBusiness and operation overview目录 Contents2020/11/273
4. Company OverviewWEBMAGAZINEBROCHURE 总部地址：湖北-武汉 Headquarter：Wuhan, Hubei Province 注册资本： 187,766.2590万元Registered capital: RMB 1.877662590 Billion 01成立日期：1999年3月9日 Found date：Mar 9,1999 变更日期：2008年11月28日整体变更为股份公司 Restructure date: Nov 28,2008 changed to joint-stock enterprise group 02上市时间：2010年11月2日（上海证券交易所） Public listed：Nov 2,2010 （Shanghai stock exchange ）股票代码：九州通 600998 Stock Code：Jointown 600998 03主营业务：医药（西药、中药、器械）分销、医院纯销、零售业务、电子商务 Business scope：Medicine( western medicine, medical device, TCM) distribution、hospital distribution、retail & pharmacy, e-commerce 04 九州通是一家以西药、中药、器械为主要经营产品，以医疗机构、批发企业、零售药店为主要客户对象，并为客户提供信息、物流等各项增值服务的大型企业集团。Jointown Pharmaceutical Group Co., Ltd. is a leading public listed company in China’s pharmaceutical commercial industry. Jointown is a large group which is mainly responsible for supplying western medicine, TCM and medical device to clients including pharmaceutical institution, wholesaler enterprise and retail pharmacy, as well as providing information, logistics and other value-added services to them . 公司概况九州通集团总部麦迪森广场2020/11/274
5. 截至2018年12月31日，九州通合并报表范围内公司367家。 By the end December 31of 2018, the consolidation of statements of Jointown Pharmaceutical Group Co., Ltd. include 367 companies. 367家 367 Companies2018年实现营业收入871.36亿元（不含税），较2017年同期增长17.84%。 2019年一季度末实现营业收入246.63亿元（不含税），较2018年同期增长11.04%。 In 2018, JPG had realized operating revenue of 87.136 bilon Yuan , which had increased of 17.84% comparing with same period in 2017. The fiirst quarter of 2019, realized revenue of RMB 24.663 Billion (exclusive of tax) with a growth over 11.04% comparing with same period in 2018.871.36 87.136 Billion截至2018年12月31日，总资产666.74亿元。 By the end December 31of 2018, total assets reached 66.674 billion yuan.666.74 66.674 Billion2018年，九州通在职员工总数26119人。 In 2018, total stuff number is 26,119 staff 26119人 26,119 Staff 公司规模Company scale九州通东西湖医药物流中心2020/11/275
6. 2015年2014年2013年2012年2011年2010年2009年495.89亿410.68亿334.38亿295.08亿248.39亿212.52亿189.58亿销售业绩Sales performance unit: 100M RMB 年均复合增长率约 20% Sales growth chart（exclusive of tax） RMBannual average compound growth rate(approx.) 2020/11/2762016年615.57亿2017年739.43亿2018年871.36亿
7. 第1位 NO. 1 中国民营医药商业企业 China＇s private owned pharmaceutical commercial enterprise第4位 NO.4 中国医药商业企业 China pharmaceutical commercial enterpriseWithin 2017yeas China＇s top 100 private owned service enterprise1425105第25位 NO. 25 2017年中国民营企业服务业100强行业地位 Industry status 企业排名 Corporate ranking 行业地位Industry status5A 5A 行业内首家5A物流企业 The first company with 5A grade logistics strength in pharmaceutical industry 5A2020/11/277第105位 NO. 105 2018年中国企业500强（财富）NO. 105 China top 500 enterprises 2018 (Fortune China）105医药行业唯一获评国家十大智能化仓储物流示范基地 the only ten intelligent logistics warehousing and logistics demonstration base in the pharmaceutical industry唯一
8. 20142015201620172018楚商优秀企业 Outstanding enterprise of Chu(Hubei province)注册商标被评为驰名商标 Registered trademark rated as a well-known trademark武汉现代服务业（物流）领军企业 The leading enterprise within Wuhan modern service industry (logistics) 荣获2015年“十大医药互联网+创新企业”称号 Awarded the title of the “Top ten pharmaceutical internet innovative enterprise" in 2015 荣誉Honor2020/11/278全国守合同重信用企业 National creditable enterprise 荣获第七届长江质量奖 Obtaining the the award of Changjiang quality in the 7th武汉市实施卓越绩效模式先进企业 Wuhan implementation of excellence performance model advanced enterprise 荣获首届湖北改革奖（企业奖） Obtaining the award of Hubei reforming in the 1st （ enterprise）获评高新技术企业、教育部科技进步一等奖、湖北省科技进步二等奖 Appraised High-tech Enterprises 、 Ministry of Education First Prize for Scientific and Technological Progress 、 Second Prize for Scientific and Technological Progress in Hubei Province 成为工信部两化融合贯标企业Become a Standard-Performing Enterprise of the Ministry of Industry and Information Technology
9. 一家药店→乡镇供销社→承包国营药企经营 One pharmacy - township SMC – contractor for state owned medicine companies2010－至今 Today 创业历程Entrepreneurial journey企业创始人刘宝林先生 Founder Mr. Liu Baolin原始积累 primitive accumulation一次创业 The first phase二次创业 The second phase成立九州通→全国网络布点→企业上市筹备 The establishment of JPG– setting up a nationwide distribution network- preparation for IPO在国内主板成功上市→完成全国90%区域布点→二次创业启动 Successfully listed – completing 90% of coverage nationwide – ahead for further development1985-1999年1999-2009年2020/11/279
10. 业务概要及经营情况经营模式及核心优势Business model and core strengths公司基本情况介绍Company overview未来发展与经营规划Future business development and planningBusiness and operation overview目录 Contents2020/11/2710
11. 利用现有配送能力、营销网络和品种资源，开办和发展的零售连锁业务模块。从事药品生产及研发业务，同时覆盖中药种植加工、配送、销售及中药研发等领域。为药品生产企业及其他供货商提供分销、物流配送与药品信息服务以及其他增值服务。医药分销主营业务（分行业及占比）Main business（Proportion of sub sectors）主营业务Main businessPharmaceutical distribution医药工业Pharmaceutical manufacturing医药零售Pharmaceutical retail医药分销Pharmaceutical distribution医药工业Pharmaceutical manufacturing医药零售Pharmaceutical retailEngaged in drug production, research and development, at the same time, covering the planting, processing, distribution, sales and research and development for traditional Chinese medicine and other fields.Provide distribution, logistics, drug information and other value-added service for drug manufacturer and other drug supplier.Use of the existing distribution capabilities, marketing network and variety resources, developing and growing the retail chain business unit. 95.97%95.97%1.78%2.25%九州通的业务范围已覆盖了整个医药行业，形成了医药制造、医药分销和医药零售及增值服务的全产业链搭建。 Jointown’s business scope has covered the entire pharmaceutical industry, formed a complete pharmaceutical chain with pharmaceutical manufacturing, pharmaceutical distribution, pharmaceutical retail and value-added services.2020/11/2711
12. 主营品规与产品Main distribution category and products55%18.2%21%5.7%西药/中成药Western drug/TCPM72,408种中药材/中药饮片 Chinese medicinal material/ ready-to-eat TCM65,282种医疗器械/计生用品 Medical device/family planning198.202种食品/保健品/化妆品 Food/healthcare/cosmetics20544种复方丹参滴丸、吲达帕胺片(寿比山)、氯沙坦钾片(科素亚)、孟鲁司特钠咀嚼片(顺尔宁) 等红花、淫羊藿、阿胶、冬虫夏草等Safflower, herba epimedium, donkey-hide gelatin, Chinese caterpillar fungus 电子血压计、X射线计算机体层摄影设备、血糖试纸、对羟基苯丙氨酸(酪氨酸)尿液检测试剂以及骨科材料等Electronic blood pressure monitor, X ray computer tomography device, Blood Glucose Test Strips, Detection reagent for the urine of hydroxyl phenylalanine (tyrosine )and bone materials雅培、费列罗巧克力、欧莱雅、高露洁等医药分销业务经营的品种范围包括但不限于西药、中成药、中药饮片、中药材、医疗器械、计生用品、保健品和化妆品等。目前公司主要经营的药品、医疗器械等品种品规35万余个。The category and products for pharmaceutical distribution business includes but not limited to western drug, Traditional Chinese Patent Medicine(TCPM),ready-to-eat TCM, Chinese Medicinal material, medical device, family planning, healthcare, cosmetics and etc. The amount of current main distribution of drugs and relevant medical devices up to around 350000 types. 西药中药器械消费品359,436个Compound danshen dripping pills, Indapamide tablets, Cozzar, Singulair,etc. Abbott, ,Ferrero chocolate,L＇OREAL, Colgate etc. 2020/11/2712
13. Chained store连锁药店客户公立医疗机构客户Public medical institutions九州通销售终端已覆盖各级医院、卫生站、诊所及终端药店，并完成了电子商务平台销售渠道的搭建。 Jointown’s sales terminals have covered all tiers of hospital, hygiene station, clinics and pharmacies, as well as completed the e-commerce sales platform establishment.商业客户Business distributors分销渠道及销售占比Distribution channel and sales proportion18.7%21%33.7%10000家上游供应商 10000 upstream suppliers 分销渠道 Distribution channel销售占比 Sales take up2020/11/2713Single pharmacy单体药店等其他客户7.3%Essential drug clients基层医疗机构客户13.3%国内知名企业 Domestic Wellknown
14. 集团整体战略 - “365” 业务组合战略 The overall strategy - ‘365’ business portfolio strategy 战略业务 Strategic imperatives 抢抓市场 Grabbing the market新兴业务 Emerging business 积极探索 Actively explore生物制品 Biological products 基金投资 Fund investment 医养融合Medical services for the aged 中药业务 TCM business 医疗器械 medical facilities 消费品 consumer goods 分销业务 Distribution business 医疗业务 Medical business 终端业务 Terminal service医药工业 Medical industry 总代理 General agency 三方物流 Third part logistics 孵化器 Incubator 药品研发 Medicine R&D1核心业务 The core business 稳中求进 Making progress while maintaining stability365
15. 集团整体战略 - 业务模式 The overall strategy - business model 打造中西成药、中药、医疗器械和消费品 4 类产品线依托物流、技术、投融资 3 大业务支撑平台开拓分销业务、医疗业务和终端业务 3 大渠道1
16. 分销业务 Pharmaceutical distribution九州通业务发展的基石 Jointown business development foundation 九州通将医药分销（商业批发+终端配送）定位为核心业务，是其他所有业务形态发展的核心支撑平台，为其他业务发展提供上下游客户资源、物流平台、分销渠道、资金支持、业务团队和品牌建设的基础和保障。 2018年实现销售收入685.55亿元，较去年同期增长15.37%。 Jointown would treat pharmaceutical distribution (including commercial wholesale + terminal distribution) as the core business, which is also the core for supporting platform for the development of all other businesses, by providing the essential needs and guarantee for downstream and upstream client resource, logistics platform, distribution channel, financial support, business team and brand building. In 2018, sales revenue reached 68.555 billion , up 15.37 percent from the same period last year.销售情况 sales status核心业务core businessSales revenue(100M Yuan)2020/11/2716
17. 医疗业务 Hospital Business九州通业务发展的基石 Jointown business development foundation强大的医药物流延伸服务能力,引领医院终端市场开拓，2018年，公司医疗机构渠道实现销售297.34亿元，较上年同期增长33.14%。其中：医院纯销方面，2018年销售收入181.95亿元，较去年同期增长24.49%；二级以下基层医疗机构销售方面，2018年实现销售收入115.39亿元，较上年同期增长49.55% A strong ability in pharmaceutical logistics extension service is helpful to complete the development of terminal market. In 2018, JPG achieved selling of 29.734 billion Yuan , which has increased 24.49% comparing to the same period in last year. Among them, In terms of net sales of hospitals, the sales revenue was 18.195 billion in 2018, up by 24.49% compared with the same period last year. In terms of sales of primary medical institutions below level 2, sales in 2018 reached 11.539 billion , up 49.55 percent from the same period last year . 销售情况 sales status核心业务core businessHospital pure pin Sales revenue(100M rmb)2020/11/2717基层医疗机构销售收入（亿元）Primary medical institution Sales revenue(100M rmb)医院纯销销售收入（亿元）
18. 终端业务——FBBC体系九州通拓展FBBC终端业务，逐步健全三大平台功能。通过大数据与业务的无缝集成，获得更多的市场产品信息，在帮助供应商和入驻药店业务增长的同时，也促进了九州通业务增长以及向平台的转型。 Jointown expanding FBBC Terminal Business and Improving the Functions of Three Platforms Through the seamless integration of big data and business, more market product information can be obtained. While helping suppliers and pharmacies grow, it also promotes the growth of Jointown ＇s business and the transformation to the platform.B2B引入纯销供应商、控销供应商、具备独家品种的商业公司等到平台经营，与九州通经营产品形成互补，共享客户，目标是成为中国最大的药品线上分销B2B平台。 he goal of introducing pure suppliers, controlled suppliers, exclusive varieties of commercial companies and other platforms to complement and share customers with Jointown ＇s products is to become China＇s largest online distribution B2B platform for pharmaceuticals. B2C将九州通会员药店发展成为网上药店，极大丰富品种结构，拓展B2C及O2O业务，目标是成为中国最大的C端药品线上交易平台之一。 To develop Jointown Membership Pharmacy into an online pharmacy, greatly enriching the variety structure, expanding the business of B2C and O2 O, the goal is to become one of the largest online trading platforms for C-terminal drugs in China智能健康依托人工智能技术，导入医院、互联网医院和远程医疗等资源，建设智能化的医和药学服务平台。 Intelligent medical and pharmaceutical service platform will be built by introducing artificial intelligence technology into hospitals, Internet hospitals, telemedicine and other resources.
19. 医药纯销中药业务医疗器械打造中国最大、最专业的医疗器械营运与服务商 2018年实现销售收入 112.21亿元，较上年同期增长60.85%。 To build China＇s largest and most professional medical device operating and service providers. Sales revenue in 2018 reached 11.221 billion , up 60.85 percent from a year earlier. 做中国中药健康产业最佳服务商 2018年实现销售收入33.97亿元，较上年同期增长20.53%。 To be the best service provider in China’s TCM Health industry. Sales revenue in 2018 reached 3.397 billion , up 20.53 percent from a year earlier. 战略业务Strategic business2020/11/27Pharmaceutical manufacturing覆盖医药工业业务全产业链 2018年实现销售收入15.45亿元，较上年同期增长29.53%。 Covering the complete industrial chain for pharmaceutical manufacturing business. In 2018, sales revenue reached 1.545 million , up 29.53 percent from the same period last year.医药工业
20. 战略业务Strategic business20消费品总代理业务做中国消费品产业最佳服务商业务渠道涵盖otc药店、母婴、商超、百货、医院、电商 2018年实现销售收入37.84亿元，较上年同期下降16.13%。 To be the best service provider in China Consumer Goods Industry Business channels covers OTC Pharmacy, mother&infant, hyper-market, department store, hospital ancommerce. In 2018, sales revenue reached 3.784 billion yuan, down 16.13 percent from a year earlier. 致力于打造覆盖全渠道的产品营销体系负责集团全国总代理产品的洽谈引进、销售管理、售后服务工作，以及自有产品的营销管理工作。 2018年实现销售收入29.33亿元，较上年同期增长67.12%。 Committed to building a product marketing system covering all channels, responsible for the group＇s national general agent product negotiation, introduction, sales management, after-sales service, and marketing management of their own products. In 2018, sales revenue reached 2.933 million , up 67.12 percent from the same period last year. 三方物流积极开发三方物流业务，并利用公司物流管理经验优势对外输出物流管理服务。 2018年实现销售收入1.74亿元，较上年同期增长59.96%。 Actively develop the Tripartite logistics business, and use the company＇s logistics management experience to export logistics management services In 2018, sales revenue reached 0.174million , up 59.96 percent from the same period last year.
21. 生物制品 Biological products医养融合 Medical services for the aged 基金投资 Fund investment 药品研发 Medical R&D孵化器 Incubator 新兴业务Emerging business2020/11/2721
22. 2018年整体经营业绩2018 annual performanceRevenueRevenue for main business-0.06-%-0.06%-0.07%Net profitNet profit for shareholder Of the parent company 单位：亿元人民币28.10%0.91%Profit2018data 2017dataTotal Assets Net Assets2020/11/27222018年数据 2017年数据17.84%17.95%
23. 西药/中成药2018年西药业务经营业绩2018 Western drug business performance中药材/中药饮片医疗器械/计生用品食品/保健品/化妆品分销业务Distribution businessWestern drug/TCPM Chinese medicinal material/ ready-to-eat TCMMedical device/family planningFood/healthcare/cosmetics15.37%2018年，西药、中成药销售继续保持快速增长，实现销售收入685.55亿元、较上年同期增长15.37%；销售毛利率8.51%，较上年同期提升0.41%From the result of 2018 business performance, it indicated that sales of western drug and TCPM rapidly growth. In fact, the operating income achieved in terms of providing western drug were 68.555 billion Yuan, which had increased 1% comparing to the last year; while the margin of gross profit was 8.51%, It was 0.41% higher than the same period last year.0.41%单位：亿元：Unit:100M RMB Sales Revenue Gross profit2020/11/27232018data 2017 data2018年数据 2017年数据
24. 20.53%0.44%2018年，中药材与中药饮片业务继续保持较好增长，实现销售收入33.97亿元、较上年同期增长20.53%；销售毛利率为13.74%，较去年同期上升0.44个百分点 From the performance of selling Chinese Medicine, it indicated that TCM and relevant services maintained a growth. The operating income earned from selling TCM were 3.397 billion Yuan, which had increased 20.53% comparing to last year; while the margin of gross profit was 13.74%, It was 0.44% higher than the same period last year.2018年中药业务经营业绩2018 Chinese Medicine business performance单位：亿元 Unit:100M RMB Sales Revenue Gross profit2020/11/2724西药/中成药中药材/中药饮片医疗器械/计生用品食品/保健品/化妆品分销业务Distribution businessWestern drug/TCPM Chinese medicinal material/ ready-to-eat TCMMedical device/family planningFood/healthcare/cosmetics2018data 2017 data2018年数据 2017年数据
25. 60.85%0.72%2018年，医疗器械与计生用品业务继续保持快速增长的势头，实现销售收入112.21亿元、较上年同期增长60.85％；销售毛利率为7.43％，较上年同期降低0.72个百分点 The medical facilities performance indicated that this areas maintained a growth trend in 2018. In fact, the operating income earned from being responsible for supply medical devices to consumers were 11.221 billion Yuan, which had increased 60.85%; while the margin of gross profit was 7.43%, which had decreased 0.72%. 2018器械业务经营业绩2018 Medical device business performance单位：亿元 Unit:100M RMB Sales Revenue Gross profit2020/11/2725西药/中成药中药材/中药饮片医疗器械/计生用品食品/保健品/化妆品分销业务Distribution businessWestern drug/TCPM Chinese medicinal material/ ready-to-eat TCMMedical device/family planningFood/healthcare/cosmetics2018data 2017 data2018年数据 2017年数据
26. 16.13%0.67%2018年，食品、保健品、化妆品等业务进行了战略调整，期内实现销售37.84亿元，较上年同期下降16.13%；销售毛利率为8.43%，较上年同期提高0.18个百分点。In 2018, the business of food, health care products and cosmetics was adjusted strategically.. JPG realized sales revenue of 37.84 billion Yuan, 16.13% lower than the same period last year. while the margin of gross profit was 8.43%, It was 0.18% higher than the same period last year.2018年消费品业务经营业绩2018 Consumer goods business performance单位：亿元 Unit:100M RMB Sales Revenue Gross profit2020/11/2726西药/中成药中药材/中药饮片医疗器械/计生用品食品/保健品/化妆品分销业务Distribution businessWestern drug/TCPM Chinese medicinal material/ ready-to-eat TCMMedical device/family planningFood/healthcare/cosmetics2018data 2017 data2018年数据 2017年数据
27. 2018年区域公司业绩（销售10亿以上）2018 Regional Company performance(with sales over 1Billion)单位：亿元 Unit:100M RMB Group Henan Beijing Guangdong Shandong Jiangsu Xinjiang Chongqing Shanghai Fujian Liaoning Hangzhou Sichuan Shanxi Lanzhou2020/11/2727
28. 前身为成立于2000年1月的湖北九州通，是华中地区规模最大的现代医药物流企业 Predecessor is the Hubei Jointown founded in Jan 2000, it is the largest modern pharmaceutical logistics enterprise in Middle China region.成立于2001年2月，位于国家郑州经济技术开发区第九大街88号Founded in February 2001, it is located at No. 88 the ninth street in Zhengzhou economic and technological development zone, 河南九州通 HeNan Jointown成立于2001年3月，位于北京市大兴区大兴经济开发区广平大街9号 Founded in November 2010, it is located at No.9 Guangping street in Beijing Daxing economic development zone of Daxing district北京九州通 Beijing Jointown成立于2002年12月，位于广东省中山市火炬开发区国家健康基地 Founded in December 2002, it is located in the national health base in the Zhongshan torch development zone of Guangdong province. 广东九州通 Guangdong Jointown 注册资本 18.79亿元 Registered capital 1.878 B销售收入 123.84亿元 Sales revenue 12.384 B注册资本 9.4亿元 Registered Capital 940M 销售收入 85.20亿元 Sales revenue 8.520 B 注册资本 7.559亿元 Registered capital 755.9 M注册资本 4亿元 Registered Capital 400 M销售收入 57.86亿元 Sales revenue 5.786 B 销售收入 49.25亿元 Sales revenue 4.925 B 集团公司（湖北本部） Headquarter (Hubei BU)Regional company（ Sales data: 2018 ）区域公司介绍（销售数据：2018年）2020/11/2728
29. 成立于2007年1月，位于南京市江宁经济开发区殷华街476号。占地面积68亩。 Founded in January 2007， 476 Yinhua Street, Jiangning Economic Development Zone, Nanjing。 It covers an area of 68 mu.江苏九州通 Jiangsu Jointown成立于2004年5月，位于乌鲁木齐高新技术产业开发区，占地面积70亩 Founded in May 2004, it is located in Wulumuqi high technology industry development zone, covers a land area of 70 acres.新疆九州通 Xinjiang Jointown成立于2007年，位于重庆市南岸区茶园新区B区江桥路2号，占地面积95亩 Founded in 2007, it is located at No. 2 Jiangqiao Rd in the B zone of the Tea Garden new zone of Nanan district in Chongqing city. 重庆九州通 Chongqing Jointown注册资本 6 亿元 Registered capital 600 M销售收入 43.46亿元 Sales Revenue 4.346 B注册资本 5.046亿元 Registered Capital 504.6M销售收入 34.89亿元 Sales Revenue1.3.489 B 注册资本 6.2亿元 Registered Capital 620 M注册资本 4.2亿元 Registered Capital 420M 销售收入 35.26亿元 Sales Revenue 3.526 B 销售收入 25.82亿元 Sales revenue 2.582 B 山东九州通 Shandong Jointown 成立于2004年8月，位于山东省济南市高新区天辰大街288号Founded in Aug 2004, it is located at No. 288 the Tianchen street in Jinan high-technology zone in Shandong province区域公司介绍（销售数据：2018年度） Regional company （ Sales data: 2018 ） 2020/11/2729
30. 成立于2002年11月，位于上海市普陀区常和路666号 Founded in Nov 2002, it is located at No.666 Changhe road, putuo district of shanghai. 上海九州通 Shanghai Jointown注册资本 2.5亿元 Registered capital 250M销售收入 25.64亿元 Sales Revenue 2.564 B 成立于2008年4月，位于沈阳市沈北新区建设路81号，占地面积100亩 Founded in April 2008, it is located at No.81 Jianshe road in Shenbei new district of Shenyang city, covers a area of 100 acres. 辽宁九州通 Liaoning Jointown注册资本 4亿元 Registered Capital 400 M 销售收入 20.07亿元 Sales Revenue 2.007 B 区域公司介绍（销售数据：2018年度）Regional company （ Sales data: 2018 ） 2020/11/2730 成立于2010年12月，位于成都市温江区海峡科技产业园新华大道二段728号 established in Dec 2010, which located in No.728, Xinhua Avenue, Haixia teconology production park, Wenjiang dChengdu. istrict, 注册资本 4亿元 Registered capital 400M销售收入 23.83亿元 Sales Revenue 1.149 B四川九州通 Sichuan Jointown成立于2004年1月，位于福州经济技术开发区，占地70亩 Founded in January 2004, it is located in fuzhou economic and technological development zone, covers an area of 70 acres.福建九州通 Fujian Jointown注册资本 3.7亿元 Registered Capital 370M 销售收入 17.05亿元 Sales Revenue 1.705 B
31. 2019年一季度经营业绩Business performance in the first quarter of 201911.04%11.07%Revenue Revenue for main business47.78%15.51%ProfitNet profit 单位：亿元人民币 UNIT: 100M RMBTotal Asset Net Asset-2.57%-4.04%In the first quarter for 2019 DATA 2018 End of year DATA2020/11/2731In the first quarter for 2019 DATA In the first quarter for 2018 DATA
32. 2019年一季度经营业绩（西药、中药、器械等业务）Western drug, TCPM8.76%8.76%39.25%-9.24%中药材、中药饮片医疗器械、计生用品食品、保健品、化妆品等单位：亿元人民币Unit:100M RMB Business performance in the first quarter of 2019 (western drug, TCM, medical device, etc.)Chinese medicinal material/ready-to-eat TCMMedical device/ family planningFood/healthcare/ cosmetics2020/11/2732In the first quarter for 2019 DATA In the first quarter for 2018 DATA
33. 业务概要及经营情况经营模式及核心优势Business model and core strengths公司基本情况介绍Company overview未来发展与经营规划Future business development and planningBusiness and operation overview目录 Contents2020/11/2733
34. 中国医药集团总公司市场份额14.33% China Pharmaceutical Group market share14.33% 华润医药商业集团有限公司市场份额 5.65% China Resources Pharmaceutical market share5.65% Commercial Group 上海医药集团股份有限公司市场份额 5.45% Shanghai Pharmaceutical market share 5.45% Group 九州通医药集团股份有限公司市场份额2.56% Jointown pharmaceutical group market share 2.56% 85%85% of medicine goes to the hospital15%15% of medicine goes to market terminal 行业经营模式Market environment of the industry面向二级及以上医疗机构为主的经营模式 Primary Business model targeted at secondary and above secondary medical institution以市场分销为主的经营模式 Primary Business model focuses on market distribution在市场化分销业务中占比近 Take up in market distribution20%2020/11/2734
35. The Jointown Model九州通模式市场化的价格形成机制 Market-oriented pricing mechanism 丰富的经营品种 Rich varieties of product 快捷的配送速度和和宽裕的服务半径 Quick delivery and ample service radiation相对宽裕的资金周转速度Relatively ample capital turnover九州通模式Jointown’s Unique Business model九州通是快批、快配分销模式的开创者，药品第三终端销售的行业龙头。 Jointown is the pioneer for fast wholesale, quick delivery model and the leader in the tertiary medicine terminal sale industry. 2020/11/2735
36. 物流配送 Custom system资金周转 Capital turnover价格机制 Pricing mechanism经营品种 Product Variety市场目标 Market targetVSJointown modelConventional model以中高端医疗机构为主 Mainly target at middle-high end medical institution以处方药为主，处方药占较大比重 prescription drugs based, prescription drugs account for larger proportion通过固定的15%加价或0差率制度 By 15% fixed add-on pricing system速度较慢 low processing speed配送服务的差异化较小 Rather small differentiation of the distribution services九州通模式与传统模式Comparison of Jointown model and conventional model 以基层医疗机构、药店及下游分销商为主 Mainly target at primary medical institution, pharmacy and downstream distributors以日常用药为主，非处方药占较大比例 Daily medicine based, non-prescription drugs account for larger proportion价格由市场供求关系决定 The price is decided by market supply and demand 速度较快 high processing speed提供差异化、精细化、高频率的物流配送服务 Provide differentiated, fine, high frequency logistics distribution services2020/11/2736
37. Excellent enterprise culture优秀的企业文化Rich customer resources丰富的客户资源Efficient execution高效的执行力Advanced logistics technology先进的物流技术Wide sales network广阔的销售网络 The leading e-commerce business platform领先的电商平台核心竞争力Core competitiveness2020/11/2737
38. 全集团GSP仓储面积：222万平方米 Total warehouse space: 2 Million Square Meter 存储能力：1000万件 Storage capacity: 10 Million pieces 出货效率：10000行/小时 Outbound efficiency:10000line/hour 出库准确率：99.99% Outbound accuracy: 99.99% 自有配送车辆：1700余台 Company owned truck: 1700针对中国医药行业特点自主研发三大系列291套专业软件产品 Self-developed 3 ranges and over 291 sets of professional software to meet Chinese pharmaceutical industrial need医药物流相关产品线 Pharmaceutical logistics related product line 医药供应链管理产品线 Pharmaceutical supply chain management product line医疗机构管理相关产品线 Pharmaceutical institution management related product line核心竞争力Core competitiveness先进的物流技术 Advanced logistics technology2020/11/2738
39. 二级公司 31 家三级公司 96 家 31 Provincial Subsidiaries 96 District City Subsidiaries 福州广东广西河南江西甘肃浙江山东上海新疆四川重庆安徽内蒙山西西藏湖南青海云南贵州台湾河北江苏北京天津辽宁吉林湖北黑龙江陕西宁夏海南已布局 CoveredNationwide sales network遍布全国的销售网络核心竞争力Core competitiveness2020/11/2739
40. Leading e-commerce business platform珍药材Precious TCMZ远程医疗Tele-medicine零售连锁Retail pharmacy好药师AppQu mai Yao online platform好药师网上药店E-haoyao Online platform健康998Health 998海外购Oversea buy核心竞争力The core competitiveness领先的电商平台2020/11/2740
41. 高效执行体系 Efficient execution system覆盖全国的营销网络 Nationwide marketing and sales network稳定的业务运营 Stable business operation健全的沟通机制 A sound communication mechanism完善的业务信息系统 Complete business information system管理集中 Centralized management业务细分 Business segmentation分公司100%控股 100% ownership of subsidiary服务质量水平 Service quality standard 公司的竞争力客户满意度 Customer satisfaction 公司竞争力 Company competitiveness 核心竞争力Core competitiveness高效的执行体系Efficient system of execution2020/11/2741
42. 核心竞争力Core competitiveness丰富的客户资源Rich customer resources31家省级物流中心 31 Provincial logistics center地级配送中心 96 Regional distribution center96 家快速到达目标市场 Quickly reach the target market4500家二级及以上中高端医院 4500 Middle and high grade hospitals 10万余家零售终端 100K Retail terminals7.5万家二级以下基层医疗机构 75K medical institutionsB2B用户 226K B2C user22.6万B2C用户 18M B2C user1800万供应商 7385 supplier7385余家经营品种 350K Operating varieties35万个828个全国性分销，物流配送网络 Nationwide distribution, logistics and distribution network 总代理品种 619 General agent varieties2020/11/2742终端配送点 400+ distribution station400 多个
43. 家庭文化 Family culture 家文化 The home culture 家园文化 Home culture 1985年1999年2006年2015年现在的家文化核心：尊重文化 Core of the current home culture : respect the culture 核心竞争力Core competitiveness优秀的企业文化Excellent enterprise cultureunique company management model: Leader serves the staff； Staff serves the client； Client is our king. Client Staff Leader 2020/11/2743
44. 业务概要及经营情况经营模式及核心优势Business model and core strengths公司基本情况介绍Company overview未来发展与经营规划Future business development and outlookBusiness and operation overview目录 Contents2020/11/2744
45. 2.集中度进一步提高 “两票制“、”营改增“、”94号文“、”新版《药品经营质量管理规范》等政策的推行，促使行业集中度进一步提升 The implementation of such policies as "two-vote system", "replacing business tax with value-added tax", "94th document", and new edition of "standards for the quality management of drug distribution" has further promoted the industrial concentration 3.行业监管趋严 5.医药电商及医院处方外流成为未来趋势探索医疗卫生机构处方信息与药品零售消费信息互联互通、实时共享，促进药品网络销售和医疗物流配送等规范发展。 Explore the interconnection and real-time sharing of prescription information and drug retail consumption information in medical and health institutions, and promote the standardized development of drug network sales and medical logistics distribution. 4.三大用药渠道面临重塑医保控费与分级诊疗的持续推进，形成药品消费渠道下沉。随着基层医疗机构的药物目录放开，慢病用会大幅度向基层医疗机构转移，现有的药品流通渠道格局未来将会药将发生巨大变化。 The continuous advancement of medical insurance control fees and graded diagnosis and treatment has resulted in the sinking of drug consumption channels. With the opening of the drug catalogue in primary medical institutions, the drug use for chronic diseases will be transferred to primary medical institutions by a large margin, and the current pattern of drug distribution channels will undergo tremendous changes in the future. 行业格局和趋势industry pattern and trend 2020/11/27451.行业增长持续放缓受宏观经济持续下行影响，同时新出台的4+7带量采购、抗癌药谈判等政策导致药价下降幅度较大，进而导致医药市场增速进一步放缓。 Affected by the sustained downward trend of macro-economy, the new 4+7 belt purchasing policy and the negotiation of anticancer drugs have led to a large drop in drug prices, which further slowed down the growth of the pharmaceutical market. 经营企业和使用单位应当配合药品上市许可持有人和生产企业，建成完整药品追溯系统，履行各自追溯责任。 Business enterprises and users shall cooperate with the holders of drug market licenses and production enterprises to build a complete drug traceability system and fulfill their respective traceability responsibilities.
46. 人口结构的老龄化趋势推动药品市场增长The aging trend of population structure promotes the drug market to grow 城镇化的推进将有效促进我国医药消费水平的上升The urbanization advancement will effectively promote the pharmaceutical consumption level in our country 健康和保健意识的不断提高，在医疗保健的费用随之持续增长Health and healthcare consciousness shows unceasing enhancement, results in sustained growth in health care costs FONTSBROCHURE增量市场挖掘Incremental market outlookThe rapid economic growth and rising per capita income of urban and rural residents, providing guarantee for the growth of the pharmaceutical market in China 经济的快速增长，城乡居民人均收入的不断增加，为我国医药市场的增长提供了保障人口老龄化加速城乡居民收入提升城镇化有效推进健康保健意识提高2020/11/2746
47. 2020/11/2747行业政策分析（2018年）Industry development trend (years 2018)三医联动，明确监管职责深化改革，严控医疗费用2018年，医药持续推进，药品流通领域的“两票制”政策全面落地、药品一致性评价持续推进、国家4+7带量采购开始试行等；与医药相关的监管机构的改革已经完成，医保局、卫健委、药监局三大机构明确了分工与监管职责，并全面而有效地开展工作。原人社部的城镇职工和城镇居民基本医疗保险、生育保险职责以及原卫计委的新型农村合作医疗职责等进行整合，组建国家医疗保障局，全面负责医保基金的管理与支付，以及药械产品的谈判、定价、采购和支付等带量采购，保质降价继续控制医疗费用不合理增长，不搞“一刀切”；扩大按病种付费，推动医疗开支的结构性调整；落实药品购销两票制等带量采购在保障药品质量的同时大幅降低药价，促进仿制药替代原研药，通过降药价和保用量，大幅降低药企销售成本，减少药代人数；同时有利推动形成以市场为主导的药品价格机制，并为未来可能实行的医保支付价探索价格基础。互联网医疗、关联的网络数据与支付管理等作了界定，从而奠定了未来互联网医疗的治理框架，明确了监管方式，如何用信息化手段保证医疗质量安全底线等。与此同时，前述规定也为处方药网络销售提供技术保障与制度基础互联网+医疗规范化
48. 强力拓展战略连锁业务，搭建中小型连锁采购平台，继续推进下游商业公司合作医疗业务强化基层医疗机构、民营医院与部队医院开拓；加快院内外药房拓展和布局。重点开拓高质量的基层医疗客户，扩大基层医疗机构覆盖率面. 搭建终端运营管理体系，提高品种满足率，继续实现FBBC平台销售及整体B2B业务销售的大幅增长. 。大力拓展大数据、AI技术，统一电商版块技术架构，优化平台及APP客户体验，提升满意度；严格风险控制，严格控制应收业务风险，提升经营质量战略方向及2016年经营规划经营规划Business plan 医药分销 B2B业务及FBBC终端业务2020/11/2748采购业务大力推进核心供应商增量，完善品类管理，关注三级公司的库存管理
49. 提升器械专业业务、常规业务、战略业务板块经营质量。加速引进具备资源的合作方投资并推进投资并购，通过全资或控股并购等方式拓展区域覆盖消费品业务强化品牌建设，聚焦以“九信”品牌的诚信中药定位，建立以质量为基础的品牌管理体系，进行品牌中药营销；拓展新的产品品种中药业务规范独立运营管控体系，全面梳理组织架构，完善并运行新业务流程；推进业务集中运营，集中管控；推进核心战略品牌全渠道拓展好药师线上：打造处方外流承接平台，搭建处方药外流专业团队，成为医疗资源优先合作的处方药供应和外配平台；好药师连锁：全面提升门店的运营管理，推动标准化运营体系的全面落实，重塑门店运营体系；大力拓展医院药房业务，试点门店合伙制，提升门店经营水平经营规划Business plan 医疗器械业务医药零售业务2020/11/2749
50. 总代理业务优化总代理组织架构，梳理业务流程，区域公司成立总代理部门与集团对应总代理事业部对接并正常运行；引进优势品种，重点关注利润提升，严格总代理品种的价格与区域管控；加速推进总代理团队建设，助推集团公司由物流分销型企业向物流分销与产品推广功能兼具型企业转型全力推进京丰制药和博山制药一致性评价，加速完成产品转移，强化产销协调筹划，重点做好通过评价后的销售规划，合理控制销售团队人数及销售费用战略方向及2016年经营规划经营规划Business plan医药工业2020/11/2750
51. 公司愿景 Vision 做中国医药健康产业最佳服务商 To be the best service provider in China’s pharmaceutical and health industry 核心价值观 Core value 责任心、危机感、执行力、融合度 Reasonability, risk awareness, execution, Fusion公司使命 Mission为医药健康产业提供高性价比服务 To provide high quality services to the pharmaceutical and health industry公司愿景公司使命核心价值观2020/11/2751
52. THANK YOU!2020/11/2752THANK YOU!

下载需要 3 香币 [ 香币充值 ]

亲，您也可以通过分享原创文档来获得香币奖励！

服务器/托管费、人工审核、技术维护等都需要很多费用，请您支持香当网的发展

下载PPT

九州通医药集团简介PPT中英文版（2018年年报数据+一季报）

该用户的其他文档

相关PPT

相关文档